Zacks Research Has Positive Outlook for PAHC FY2026 Earnings

Phibro Animal Health Corporation (NASDAQ:PAHC) – Analysts at Zacks Research increased their FY2026 earnings per share estimates for shares of Phibro Animal Health in a note issued to investors on Wednesday, December 10th. Zacks Research analyst Team now forecasts that the company will post earnings of $2.75 per share for the year, up from their prior forecast of $2.73. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q1 2027 earnings at $0.72 EPS, Q3 2027 earnings at $0.68 EPS, FY2027 earnings at $2.74 EPS and FY2028 earnings at $3.02 EPS.

PAHC has been the topic of several other research reports. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 8th. Bank of America boosted their price objective on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research note on Friday, August 29th. Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a research note on Thursday, August 28th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $31.40.

Phibro Animal Health Stock Up 1.3%

Phibro Animal Health stock opened at $40.67 on Monday. The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $46.42. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of 24.50, a P/E/G ratio of 1.14 and a beta of 0.77. The firm has a 50 day simple moving average of $41.29 and a 200 day simple moving average of $34.77.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. The business had revenue of $363.89 million for the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 26th. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. Phibro Animal Health’s dividend payout ratio is presently 28.92%.

Insiders Place Their Bets

In other news, CEO Jack Bendheim sold 5,752 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $40.93, for a total transaction of $235,429.36. Following the completion of the transaction, the chief executive officer directly owned 39,200 shares of the company’s stock, valued at $1,604,456. The trade was a 12.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last ninety days, insiders have sold 153,576 shares of company stock valued at $6,621,149. Company insiders own 50.13% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. National Bank of Canada FI acquired a new stake in shares of Phibro Animal Health in the 1st quarter valued at about $30,000. Financial Management Professionals Inc. bought a new position in Phibro Animal Health during the 2nd quarter valued at $32,000. Hughes Financial Services LLC bought a new position in Phibro Animal Health during the third quarter valued at $40,000. iSAM Funds UK Ltd purchased a new position in Phibro Animal Health during the third quarter valued at approximately $61,000. Finally, EverSource Wealth Advisors LLC grew its stake in Phibro Animal Health by 7,671.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after buying an additional 2,685 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.